PRESS RELEASE published on 08/02/2023 at 14:30, 3 years 3 months ago REMINDER: Napo Pharmaceuticals, a Jaguar Health Company, Supports Gay Men's Health with Participation in Pineapple Healthcare's "Butt Stuff Brunch with Dr. Carlton" August 5th
PRESS RELEASE published on 08/01/2023 at 14:40, 3 years 3 months ago Jaguar Health Announces FDA Activation of Third-Party Investigational New Drug (IND) Application for Evaluation of Crofelemer for Treatment of Uncontrolled Diarrhea in Patient with Short Bowel Syndrome (SBS)
PRESS RELEASE published on 07/27/2023 at 14:30, 3 years 3 months ago In Honor of World Nature Conservation Day, Jaguar Health Announces Planting of More Than 1.1 Million Trees in Peruvian Amazon
PRESS RELEASE published on 07/26/2023 at 14:30, 3 years 3 months ago Jaguar Health Names Principal Investigators for Clinical Trial to Support Full Approval of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
PRESS RELEASE published on 07/25/2023 at 14:30, 3 years 3 months ago Napo Pharmaceuticals, a Jaguar Health Company, Supports Gay Men's Health with Participation in Pineapple Healthcare's "Butt Stuff Brunch with Dr. Carlton"
PRESS RELEASE published on 07/07/2023 at 22:15, 3 years 4 months ago Jaguar Health Reports Approval of All Proposals at 2023 Annual Meeting of Stockholders
PRESS RELEASE published on 06/28/2023 at 14:30, 3 years 4 months ago Napo Pharmaceuticals, a Jaguar Health Company, Submits Investigational New Drug (IND) Application to FDA for Microvillus Inclusion Disease
PRESS RELEASE published on 06/26/2023 at 14:30, 3 years 4 months ago First U.S.-Based Canine Cancer Registry, Founded by Jaguar Health, Joins International Network to Help Advance Canine and Human Cancer Research
PRESS RELEASE published on 06/22/2023 at 14:30, 3 years 4 months ago Jaguar Health Launching AI-Driven Social Media Disease Awareness Education Series Regarding Cancer Therapy-Related Diarrhea in Dogs and People
PRESS RELEASE published on 06/20/2023 at 14:30, 3 years 4 months ago Jaguar Health Subsidiary Becomes Corporate Partner of Multinational Association of Supportive Care in Cancer (MASCC)
Published on 11/11/2026 at 16:30, 54 minutes ago ShelfieTech Announces Expansion Agreement for Its Next-Generation AI Retail Intelligence Platform
Published on 11/11/2026 at 14:25, 2 hours 59 minutes ago Route1 Announces 2026 Annual Meeting Results
Published on 11/11/2026 at 14:00, 3 hours 24 minutes ago PPX Mining Reports Callanquitas Operating Results for the First Nine Months of 2026
Published on 11/11/2026 at 14:00, 3 hours 24 minutes ago NuRAN Wireless Board Approves Growth Strategy to Scale Recurring Revenue from 5,000+ Contracted Towers
Published on 11/11/2026 at 13:15, 4 hours 9 minutes ago Amarc Extends 2026 Exploration Program at the Duke District: Initiates Drilling Program at Established Porphyry Copper-Gold Targets
Published on 11/11/2026 at 17:05, 19 minutes ago EQS-Adhoc: Mutares signs agreement to sell Guascor Energy to Oaktree for an Equity Value of EUR 74.0 million
Published on 11/11/2026 at 16:51, 33 minutes ago Research Dynamics - Report on CPHN: Investor Day Update
Published on 11/11/2026 at 16:45, 39 minutes ago EQS-Adhoc: Ad-hoc: Gerhard Hanke appointed CEO of Wienerberger AG
Published on 11/10/2026 at 18:00, 23 hours 24 minutes ago Déclaration du nombre total des droits de vote et du nombre d’actions au 31 octobre 2026
Published on 11/10/2026 at 17:45, 23 hours 39 minutes ago Damartex / Descriptif du programme de rachat d'actions
Published on 11/10/2026 at 17:35, 23 hours 49 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 octobre 2026
Published on 11/10/2026 at 17:31, 23 hours 52 minutes ago CNP Assurances SA annonce le succès de l’émission d’une obligation subordonnée Tier 2 de 500 M€.
